Ames National Corp
ATLONasdaqCIK 1132651FinancialsFiscal year ends Dec 31
Reports and events: 259 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1620:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-032805 |
| 2026-08-1320:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-027669 |
| 2026-08-0720:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026572 |
| 2026-07-1720:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-023763 |
| 2026-05-1520:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-017380 |
| 2026-05-0816:42 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015819 |
| 2026-05-0113:25 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-014331 |
| 2026-04-2420:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-013322 |
| 2026-03-1313:00 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001437749-26-008067 |
| 2026-03-1220:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-007976 |
| 2026-02-1321:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004104 |
| 2026-01-2321:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001905 |
| 2025-11-1321:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-034867 |
| 2025-11-0718:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033807 |
| 2025-10-1720:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-031265 |
| 2025-08-1320:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-026519 |
| 2025-08-0818:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025672 |
| 2025-07-1820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-023002 |
| 2025-05-0916:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015713 |
| 2025-05-0220:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-014324 |
| 2025-04-1720:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-012286 |
| 2025-03-1413:00 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001437749-25-007627 |
| 2025-03-1219:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-007223 |
| 2025-02-1421:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-003996 |
| 2025-01-2421:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-001789 |
| 2024-11-1421:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035300 |
| 2024-11-0818:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034149 |
| 2024-10-1820:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-031552 |
| 2024-08-1620:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027098 |
| 2024-08-0917:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025737 |
| 2024-07-1920:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-023078 |
| 2024-05-0920:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-015700 |
| 2024-05-0820:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015359 |
| 2024-04-2620:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-013415 |
| 2024-04-1920:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-012555 |
| 2024-03-1220:03 ET | DEF 14A | Proxy statementPeriod 2024-04-24 | 0001437749-24-007444 |
| 2024-03-0817:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-007097 |
| 2024-02-1521:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-004373 |
| 2024-01-1921:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-001720 |
| 2023-11-0921:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-031253 |
| 2023-11-0721:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-030643 |
| 2023-10-2020:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-028680 |
| 2023-08-1020:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-023026 |
| 2023-08-0820:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-022512 |
| 2023-07-2120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-020440 |
| 2023-05-1220:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-014221 |
| 2023-05-1218:30 ET | 8-K/A | 5.07 Shareholder vote results | 0001437749-23-014170 |
| 2023-05-0920:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-013295 |
| 2023-04-2819:58 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-011608 |
| 2023-04-2120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-010813 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.